Company analysis: CrowdStrike

Summary

CrowdStrike Holdings, Inc. (CRWD) is a cloud-delivered cybersecurity vendor centered on the Falcon platform, sold primarily as subscription software with usage-based and bundled constructs (notably Falcon Flex). The model is designed to expand within customers over time via additional modules (endpoint, identity, cloud security, log management/next-gen SIEM, threat intel, etc.), with Annual Recurring Revenue (ARR) and net new ARR as key operating indicators. The company positions its core competency as AI-native detection/response at scale, leveraging telemetry and data network effects to improve efficacy and automate workflows. Market position remains strong in endpoint and broader security platform consolidation, with competitive advantages typically cited as: (1) single-agent architecture and cloud delivery, (2) breadth of modules enabling consolidation, and (3) strong go-to-market execution that converts initial landings into multi-module expansions. Recent results reinforce this: in fiscal 2Q27 (quarter ended July 31, 2026), ARR reached $5.84B (+25% YoY) and net new ARR was $332.8M. Management also raised FY27 net new ARR growth guidance by 630 bps to 34% YoY at the midpoint, signaling confidence in demand and pipeline conversion. (ir.crowdstrike.com) Guidance is the most material near-term datapoint: for FY27 (ending January 31, 2027), CrowdStrike guided revenue to $5.991B–$6.011B and non-GAAP diluted EPS to $1.25–$1.26; for 3Q27, revenue to $1.523B–$1.529B and non-GAAP EPS to $0.31. (crowdstrike.gcs-web.com) These figures, combined with ARR acceleration, have supported a constructive analyst consensus (e.g., FT/Markit shows a median 12-month target of $240 with a broad range). (markets.ft.markitdigital.com) Valuation remains the key investor tension. Based on market data around September 8, 2026, CRWD closed near $210.00 per share. (eoddata.com) Using ECB’s EUR reference rate (USD per EUR = 1.1614 on September 8, 2026), that implies an indicative price of ~€180.8 per share (USD/1.1614). (ecb.europa.eu) Forward P/E is extremely elevated (StockAnalysis shows ~149x–151x forward P/E around early September 2026), meaning the equity is priced for sustained high growth and continued margin/FCF scaling. (stockanalysis.com) Outlook (short- to medium-term): operational momentum is supported by raised FY27 guidance and strong ARR/net-new ARR, but the stock’s high forward multiple increases sensitivity to any deceleration in net new ARR, billings/collections dynamics, or margin/FCF conversion. The next 1–2 quarters are therefore primarily a “delivery vs. valuation” setup: execution can sustain the premium, while even modest guide-down risk can compress multiples quickly.

Key Takeaways

1. Q2 FY27 showed strong subscription momentum: ARR $5.84B (+25% YoY) and net new ARR $332.8M, supporting the platform-consolidation thesis. (ir.crowdstrike.com)
2. Management raised FY27 net new ARR growth guidance by 630 bps to 34% YoY at the midpoint—one of the most decision-relevant recent datapoints for the stock. (sec.gov)
3. FY27 guidance was raised to revenue $5.991B–$6.011B and non-GAAP EPS $1.25–$1.26, with Q3 FY27 revenue guided to $1.523B–$1.529B. (crowdstrike.gcs-web.com)
4. Valuation is the main risk: forward P/E is roughly ~149x–151x (source-dependent), leaving limited room for execution misses. (stockanalysis.com)
5. In EUR terms, using Sep 8, 2026 close near $210 and ECB USD/EUR 1.1614, the implied price is ~€180.8; EUR investors should track FX as a secondary driver of returns. (eoddata.com)

Action Ideas

Contrarian Insights

• • Contrarian (bearish vs. common ‘quality-at-any-price’ stance): the key risk is not demand, but valuation math—forward P/E around ~149x–151x means even a small downgrade in growth expectations can drive a disproportionate price adjustment, independent of long-term product leadership. (stockanalysis.com)
• • Contrarian (bullish vs. ‘overvalued’ narrative): the magnitude of the FY27 net new ARR growth guidance increase (to 34% YoY midpoint) suggests the company is capturing consolidation budgets faster than many models assume; if ARR expansion persists, near-term valuation screens may remain poor predictors of performance. (ir.crowdstrike.com)